ArticleOncoTargets and therapy2020

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports.

Xuefei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.